Multiple pathways of cell invasion are regulated by multiple families of serine proteases

Clinical and Experimental Metastasis

Volumn 19, Issue 3, 2002, Pages 193-207

  Del Rosso, Mario ^a   Fibbi, Gabriella ^a   Pucci, Marco ^a   D'Alessio, Silvia ^a   Del Rosso, Angela ^a   Magnelli, Lucia ^a   Chiarugi, Vincenzo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

PARs; Serine proteases; Thrombin; Tissue factor; Type II transmembrane serine proteases; u PA; u PAR

Indexed keywords

SERINE PROTEINASE; THROMBIN; THROMBIN RECEPTOR; THROMBOMODULIN; THROMBOPLASTIN; UROKINASE; UROKINASE RECEPTOR;

CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL INVASION; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; HUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

ANIMALS; CELL ADHESION; CELL MOVEMENT; HUMANS; LIGANDS; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; PLASMIN; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; SERINE ENDOPEPTIDASES; THROMBIN; THROMBOPLASTIN; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036111235     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015531321445     Document Type: Review

References (117)

1. Plasminogen activators, tissue degradation, and cancer
2. Experimental alteration of the ability of tumor cells to lyse plasma clots in vitro
3. The hypoxic response: Huffing and HIFing
4. The molecular basis of the hypoxia response pathway: Tumor hypoxia as a therapy target
5. Hypoxia inducible factor alpha (HIF-alpha) is a non-heme protein. Implications for oxygen sensing
6. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation
7. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
8. Angiogenesis in cancer, vascular, rheumatoid and other diseases
9. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy
10. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy
11. A role for tissue factor in cell adhesion and migration mediated by interaction with Actin-binding Protein 280
12. Cytological observations on carcinoma
13. Fibrin as a component of the tumor stroma: Origins and biological significance
14. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis
15. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness
16. The plasminogen activation system in tumor growth, invasion, and metastasis
17. Caveolae, DIGS the dynamics of sphingolipid-cholesterol microdomains
18. GPI-microdomains: A role in signalling via immunoreceptors
19. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
20. Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology
21. Cell-surface acceleration of urokinase-catalyzed receptor cleavage
22. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer
23. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand
24. Regulation of urokinase/urokinase receptor interaction by heparin-like glycosaminoglycans
25. The urokinase-type plasminogen activator system in cancer metastasis: A review
26. No grip, no growth: The conceptual basis of excessive proteolysis in the treatment of cancer
27. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity
28. Identification of the urokinase receptor as an adhesion receptor for vitronectin
29. The urokinase receptor is a major vitronectin-binding protein on endothelial cells
30. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
31. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
32. M6P/IGFII-receptor complexes urokinase and plasminogen for activation of transforming growth factor beta1
33. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon clustering in the human kidney epithelial tumor cell line TLC-598
34. A urokinase receptor-associated protein with specific collagen binding properties
35. Plasminogen activators, integrins and the coordinated ragulation of cell adhesion and migration
36. Role of urokinase receptor and caveolin in regulation of integrin signaling
37. The serpin PAI-1 inhibits cell migration by blocking integrin ανβ3 binding to vitronectin
38. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation
39. Urokinase (uPA) and ist inhibitor PAI- 1 are strong and independent prognostic factors in node-negative breast cancer
40. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
41. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal carcinoma
42. Grutzner Ku Tumor-associated proteases and inhibitors in gastric cancer: Analysis of prognostic impact and individual risk protease patterns
43. Physiological consequences of loss of plasminogen activator gene function in mice
44. Generation and characterization of urokinase receptor-deficient mice
45. Pedersen Io Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria
46. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells
47. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
48. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity
49. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis
50. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes
51. Urokinase and tissue-type plasminogen activators in keratinocytes during wound reepithelization in vivo
52. Annexin II and regulation of cell surface fibrinolysis
53. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression
54. Mechanisms of metastasis
55. Tissue factor: Molecular recognition and cofuctor function
56. Selective cellular expression of tissue factor in human tissues
57. Observations on the cell biology of tissue factor in endothelial cells
58. The role of leukocytes in the activation of blood coagulation
59. Thrombosis in cancer patients
60. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280
61. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation
62. Fibroblasts restrict tissue factor from vescicles which form in response to low concentrations of detergent
63. Molecular cloning, expression, and partial characterization of a second human tissue-factor pathway inhibitor
64. Extrecellular matrix-associated serine protease inhibitors (Mr 33 000, 31 000 and 27 000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2
65. Tissue factor pathway inhibitor and the revised theory of coagulation
66. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2) decreases the invasiveness of prostate cancer cells in vitro
67. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer
68. A membrane-mediated catalytic event in prothrombin activation
69. The roles of fibrinogen and fibrin in hemostasis and thrombosis
70. Thrombin induces endothelial cell growth via both proteolytic and non-proteolytic pathway
71. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor
72. Proteinase-activated receptors
73. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function
74. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
75. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation
76. Thrombin promotes endothelial cell alignement in matrigel in vitro and angiogenesis in vivo
77. Effects of thrombin/thrombosis in angiogenesis and rumor progression
78. Alpha-thrombin induces transforming growth factor-beta(1) mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor
79. Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis
80. Thrombin rapidly and efficiently activates gelatinase A in human microvascular endothelial cells via a mechanism independent of active MT1 matrix metalloproteinase
81. Tumor angiogenesis: Thrombin and metalloproteinases in focus
82. Solid tumor cells express functional tethered ligand threombin receptor
83. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding
84. Thrombin receptor overexpression in malignant and physiological invasion processes
85. Role of thrombin receptor in breast cancer invasiveness
86. Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix
87. Thrombin increases the metastatic potential of tumor cells
88. Role of platelets, thrombin, integrin IIb-llIa, fibronectin and Von Willenrand factor on tumor adhesion in vitro and metastasis in vivo
89. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: Role of platelet glycoproteins P-selectin and GPIIb-IIIa
90. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the ανβ5 integrin
91. Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2
92. Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor
93. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin
94. The roles of protein C and thrombomodulin in the regulation of blood coagulation
95. Purification and characterization of two forms of soluble TM from human urine
96. Thrombomodulin inhibits intrahepatic spread in human hepatocellular carcinoma
97. An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential
98. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and function assay
99. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin
100. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes
101. Cellular localization of membrane-type serine protease 1 and identification of protease activated receptor-2 and single chain urokinase-type plasminogen activator as substrates
102. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart
103. Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth
104. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer
105. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk
106. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast
107. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2
108. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer
109. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
110. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation
111. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease
112. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease
113. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts
114. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells